19
Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

Embed Size (px)

Citation preview

Page 1: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

Polycystic Ovary Syndrome

Krishna B. Singh, MDDepartment of Obstetrics & GynecologyLSU Health Sciences CenterShreveport, LA

Page 2: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

PCOS: Learning Objectives

After viewing this slide show, you’ll be able to understand that...

-PCOS is a common endocrine disorder-Multifactorial, heterogeneous condition-Clinical manifestations affect menses,

fertility-Multiple hormonal, biochemical

changes-Long-term implications are important

Page 3: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

PCO Syndrome: Topics

Historical review Incidence Clinical features Diagnosis Management Summary

Page 4: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

PCOS: Literature Review

Sclerocystic ovaries were described by Chereau (1844); Pozzi (1894); Waldo (1895)

Stein/Leventhal first described seven cases of infertility associated with enlarged polycystic ovaries (1935)

The NIH Consensus Conference (1990) The Rotterdam PCOS Consensus Group (2003)

Page 5: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

Incidence: PCO Syndrome

The incidence varies: 5-10% (~5% USA) About 25% normal women may have

PCO by ultrasound criteria (BMJ 1986) Ultrasound findings don’t correlate with

serum hormone levels

Page 6: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

Features of PCO Syndrome

Symptoms present since puberty: Cyclic menses with luteal-phase progesterone deficiency; hirsutism; hyperandrogenemia; infertility; chronic anovulation/miscarriages

Irregular menses in 25-75% women Obesity (60%); also non-obese women Hirsutism and/or acne (virilization rare)

Page 7: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

Polycystic Ovarian Disease

PCO disease can be seen in women with pituitary neoplasms, hypo- or hyperthyroidism, diabetes, adrenal and pelvic neoplasms

Rule out PCOD to diagnose PCO syndrome Long-term care is important. Studies have

shown increased incidence of hypertension, hyperlipidemia and diabetes. Risk for CVD increased

Page 8: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

PCO Syndrome: Facts/correlates

Genetic factors: autosomal or X-linked Positive correlations of androgen and

insulin levels in some studies Ultrasound findings don’t correlate with

serum hormone levels

Page 9: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

Theories of PCO Syndrome PCO syndrome is a multifactorial disorder Theories are based on data in selected women Brain and limbic system control the

hypothalamus-pituitary-ovarian axis needed for reproductive cycle initiation and maintenance

Feedback CNS abnormality results in PCOS

Page 10: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

CNS theories of PCO Beta-endorphin theory: Higher plasma levels

are found in women with PCO syndrome Progesterone deficiency/estrogen excess is

the key component Hyperandrogenism also important in PCO

women Hyperprolactinemia may cause breast

symptoms, diminish libido, and alter moods in some women

Page 11: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

More PCO Theories... Rat PCO model: Persistent-estrus syndrome

Constant-light exposure; androgenized rat model; hypothalamic lesions

Other methods (DHEAS model) Monkey model: testosterone injections Human model: transvestites given

androgens

Page 12: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

Diagnosis of PCO Syndrome

History and physical examination important; selected laboratory and hormonal tests during several visits are needed for confirmation

Both structured and descriptive notes are evaluated by the physician

Follow-up visits arranged @ regular intervals

Page 13: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

PCOS: Differential Diagnosis Laboratory tests for confirmation:

LH/FSH, T Baseline values: Chem-22 @ morning Baseline serum hormones @ morning Pelvic ultrasound in some cases required Consider PCOD versus PCO syndrome

Page 14: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

PCOS: Key to Diagnosis Rule out conditions which may require

referral; focus on the presenting signs and symptoms

Beware of misdiagnosis “on the fly” Beware of differential diagnosis History and physical exam; selected tests Know when to refer patients and where

Page 15: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

PCOS: Management Options

Principal components: Confirm diagnosis and identify category; identify and manage concurrent illness; identify and manage patient needs

There are numerous options for successful PCO management

Page 16: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

PCOS: Treatment Options General measures: diet, exercise, relaxation

for stress management Contraception: OCP; DMPA Hormones/drugs: Provera; Parlodel;

Clomiphene; hMG/hCG; IVF in selected women

Newer drugs for treatment of obesity, hyperinsulinemia, hyperandogenemia and hirsutism

Page 17: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

PCO Syndrome and Infertility

About 60% PCO patients will have ovulatory cycles and pregnancy on clomiphene alone

About 50% PCO patients will respond to the combined clomiphene and dexamethasone within six months of treatment

Page 18: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

PCO Syndrome: Summary

PCO syndrome remains an enigma despite many scientific studies done during the last three decades

Theories of PCO abound; terminology used may be confusing and definitions are not standardized

There are many treatment options

Page 19: Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA

What This Means... Polycystic ovary syndrome is a common

disorder among reproductive age group of women; these women generally have irregular menstrual cycles

PCO has many facets of clinical presentation PCO can be successfully managed and treated

by conventional means